Publications by authors named "Igor Odintsov"

Claim this Profile
H
High-Grade Early-Onset Prostate Cancer: Assessment of TMPRSS2::ERG -Negative Tumors Suggests Low Frequency of Germline Alterations and a Pathogenic Role for HOXB13.
Daisy Maharjan, Stephanie Siegmund, Květoslava Michalova, Igor Odintsov, Jason L Hornick

Am J Surg Pathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC4-positive Fibroblastoma: A Distinctive Hyalinized Spindle Cell Neoplasm With Aberrant Nuclear Beta-catenin Expression and Frequent Biallelic Inactivation of APC.
Federico Repetto, Igor Odintsov, Lynette M Sholl, Jason L Hornick, William J Anderson

Am J Surg Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genomic Landscape of NSCLC in Systemic Sclerosis Reveals Frequent TP53 Mutations and a Paucity of Actionable Oncogenes.
Igor Odintsov, Mark M Hammer, Biagio Ricciuti, Federica Pecci, Mark M Awad

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Signature in Cancers Following Solid Organ or Allogeneic Stem Cell Transplantation.
Igor Odintsov, Stephanie E Siegmund, Navin R Mahadevan, Alanna J Church, Lynette M Sholl

Mod Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic correlates of malignancy in TFE3-rearranged PEComa: a series of 14 cases.
David J Papke, Igor Odintsov, Navin R Mahadevan, Christopher Dm Fletcher, John Hanna

Histopathology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping Mutations.
Federica Pecci, Prashasti Agrawal, Jessica S Ross, Biagio Ricciuti, Seshiru Nakazawa, Igor Odintsov

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.
Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov, Tom Zhang, Ryan Cheng

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Giant Cell Tumor of Bone: A Clinicopathologic Series of 28 Cases Highlighting Genetic Differences Compared With Conventional, Atypical, and Metastasizing Conventional Tumors.
David J Papke, S Krisztian Kovacs, Igor Odintsov, Jason L Hornick, Kevin A Raskin

Am J Surg Pathol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.
Seshiru Nakazawa, Federica Pecci, Igor Odintsov, Dimitris Gazgalis, Felix H Gottlieb

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.
Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty, Guilherme Rossato De Almeida, Igor Odintsov

JCO Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Gene Fusions in Melanoma: First Kinase Domain Duplication, New Fusion Partners, and Clinical Outcomes.
Igor Odintsov, Dale Davis, Daniel Pissaloux, Franck Tirode, Arnaud de la Fouchardiere

Am J Surg Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odontogenic Myxoma Harbors Widespread Loss of Heterozygosity and Not Trisomies.
Igor Odintsov, Tony G Kleijn, Scott T Ryall, Baptiste Ameline, Fei Dong

Am J Surg Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of Cardiac Angiosarcoma Reveals Novel Targetable KDR Variants, Recurrent MED12 Mutations, and a High Burden of Germline POT1 Alterations.
Igor Odintsov, David J Papke, Suzanne George, Robert F Padera, Jason L Hornick

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear Cell Stromal Tumor of the Lung: Clinicopathologic, Immunohistochemical, and Molecular Characterization of Eight Cases.
Igor Odintsov, Alexandra Isaacson, Karen J Fritchie, Yin P Hung, Pooria Khoshnoodi

Mod Pathol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelioid Fibrous Histiocytoma Is on a Continuum With Superficial ALK -rearranged Myxoid Spindle Cell Neoplasm : A Clinicopathologic Series of 35 Cases Including Alternate RET and NTRK3 Fusions.
Mia S DeSimone, Igor Odintsov, Harrison K Tsai, Brendan C Dickson, Ahmed K Alomari

Am J Surg Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.
Tom Zhang, Christopher A Febres-Aldana, Zebing Liu, Jenna-Marie Dix, Ryan Cheng, Igor Odintsov

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and Amplification.
Arielle Elkrief, Igor Odintsov, Roger S Smith, Morana Vojnic, Takuo Hayashi

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of targeted therapies for central nervous system metastases.
Alexander J Pfeil, Joshua D Hale, Tiger S Zhang, Kentaro Wakayama, Isao Miyazaki, Igor Odintsov

Dis Model Mech· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myxoid Inflammatory Myofibroblastic Sarcoma: Clinicopathologic Analysis of 25 Cases of a Distinctive Sarcoma With Deceptively Bland Morphology and Aggressive Clinical Behavior.
David J Papke, Igor Odintsov, Brendan C Dickson, Marisa R Nucci, Abbas Agaimy

Am J Surg Pathol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.
Igor Odintsov, Maisam Makarem, Mizuki Nishino, Sara Emily Bachert, Tom Zhang

J Thorac Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers in non-small cell lung carcinoma.
Igor Odintsov, Lynette M Sholl

Pathology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A visual-language foundation model for computational pathology.
Ming Y Lu, Bowen Chen, Drew F K Williamson, Richard J Chen, Ivy Liang, Igor Odintsov

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
Hibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, Junqin He, Alissa Poteete, Igor Odintsov

J Thorac Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Isao Miyazaki, Igor Odintsov, Keiji Ishida, Allan J W Lui, Masanori Kato

Nat Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Isao Miyazaki, Igor Odintsov, Keiji Ishida, Allan J W Lui, Masanori Kato

Nat Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis